Showing results (161-170 of 205) with videos related to

Sort By:
Pageof 21
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2022
Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHDSybille Landwehr-Kenzel, Leonie Müller-Jensen, Joern-Sven Kuehl, et al.
Mbio|September 19, 2020
Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 PatientsJaana Westmeier, Krystallenia Paniskaki, Zehra Karaköse, et al.
BMC Infectious Diseases|November 22, 2023
Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescentsKrystallenia Paniskaki, Sarah Goretzki, Moritz Anft, et al.
Nature Communications|May 24, 2019
Killer-like receptors and GPR56 progressive expression defines cytokine production of human CD4+ memory T cellsKim-Long Truong, Stephan Schlickeiser, Katrin Vogt, et al.
Frontiers in Immunology|March 2, 2023
Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantationBenedikt Obermayer, Luisa Keilholz, Thomas Conrad, et al.
Scientific Reports|June 28, 2023
Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019Adrian A N Doevelaar, Martin Bachmann, Bodo Hölzer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 27, 2021
Risk factors for Epstein-Barr virus reactivation after renal transplantation: Results of a large, multi-centre studyArturo Blazquez-Navarro, Chantip Dang-Heine, Patrizia Wehler, et al.
Kidney International|June 28, 2020
Nuclear antigen-reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneysDimas Abdirama, Sebastian Tesch, Anna-Sophie Grießbach, et al.
European Journal of Immunology|March 5, 2022
Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccinationDoris Urlaub, Natalie Wolfsdorff, Jan-Erik Hoffmann, et al.
Molecular Therapy. Methods & Clinical Development|March 7, 2022
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patientsLena Peter, Désirée Jacqueline Wendering, Stephan Schlickeiser, et al.
Pageof 21